U.S. Markets close in 5 hrs 52 mins

  • S&P 500

    4,146.20
    -17.80 (-0.43%)
     

  • Dow 30

    34,094.69
    -62.00 (-0.18%)
     

  • Nasdaq

    12,040.86
    -72.93 (-0.60%)
     

  • Russell 2000

    1,961.66
    -10.95 (-0.56%)
     

  • Crude Oil

    77.91
    +0.77 (+1.00%)
     

  • Gold

    1,885.30
    +0.50 (+0.03%)
     

  • Silver

    22.34
    +0.17 (+0.76%)
     

  • EUR/USD

    1.0722
    -0.0009 (-0.0858%)
     

  • 10-Yr Bond

    3.6790
    +0.0050 (+0.14%)
     

  • Vix

    18.81
    +0.15 (+0.80%)
     

  • GBP/USD

    1.2057
    +0.0005 (+0.0422%)
     

  • USD/JPY

    131.4160
    +0.3440 (+0.2624%)
     

  • BTC-USD

    23,027.70
    +48.93 (+0.21%)
     

  • CMC Crypto 200

    531.80
    -5.10 (-0.95%)
     

  • FTSE 100

    7,908.35
    +43.64 (+0.55%)
     

  • Nikkei 225

    27,606.46
    -79.01 (-0.29%)
     

Mersana Inks Cancer Therapy Development Deal With Merck Germany

Vandana Singh
·1 min read

  • Mersana Therapeutics Inc (NASDAQ: MRSN) signed a deal for developing antibody-drug conjugates (ADCs) for cancer treatment with Germany's Merck KGaA (OTC: MKGAF) (OTC: MKKGY).

  • Mersana would receive $30 million in an upfront payment and up to $800 million in development, regulatory and commercial milestones.

  • Related: Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy.

  • Under the agreement, Mersana would develop cancer drug candidates against up to two targets that would utilize its platform to combine Merck KGaA's proprietary antibodies.

  • Pre-clinical activities will be split between the companies. Merck Germany will be solely responsible for all clinical development and potential commercialization activities relating to any resulting product candidates.

  • Mersana said it was also eligible to receive royalties of up to low double-digit percentages on global net sales for any approved ADCs developed under the agreement.

  • Price Action: MRSN shares are down 2.68% at $5.82 on the last check Friday.

  • Photo Via Company

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • Google announces new AI search features, as race with Microsoft heats up

    Google debuted a number of new AI-powered search features at an event on Wednesday, as it fights off a new advance by Microsoft into the search market.

  • Lumen (LUMN) Q4 Earnings Beat Estimates, Revenues Fall Y/Y

    Lumen's (LUMN) Q4 performance was affected by decline in revenues across all segments.

  • Why Biden’s 4% buyback tax could boost stock prices and dividends

    The Biden administration’s new stock buyback tax will have little impact on the overall stock market. This tax has set off alarm bells in some corners of Wall Street, on the theory that buybacks were one of the biggest props supporting the past decade’s bull market — and anything weakening that prop could lead to much lower prices. One reason is that the new excise tax — whether 1% or 4% — is applied to net buybacks — repurchases in excess of how many shares the corporation may have issued.

  • Better AI Stock: C3.ai vs. Palantir Technologies

    C3.ai (NYSE: AI) and Palantir (NYSE: PLTR) represent two different plays on the secular growth of the enterprise AI software market. C3 develops AI algorithms that can be integrated into an organization's existing software to automate tasks, improve employee safety, cut costs, and detect fraud. Palantir's platform accumulates large amounts of information from disparate sources to help organizations make better data-driven decisions.

  • No wonder Powell didn’t commit to extra hikes. Here are five reasons the January jobs report may be too good to be true.

    Traders took heart that Fed Chair Jerome Powell, when he wasn’t being questioned by David Rubinstein on how he gets by on $190,000 per year, didn’t commit on Tuesday to having to be even more aggressive on interest rates given the huge 517,000 surge in nonfarm payrolls. Powell said rates would have to go even higher than the market currently expects “if we continue to get” strong labor market or higher inflation reports. Economists at Morgan Stanley point out that the January number reflects three factors it believes to be temporary: unusually warm weather, the resolution of California higher-education strikes and a very strong seasonal adjustment boost.

  • NIO Inc. (NIO) Stock Sinks As Market Gains: What You Should Know

    NIO Inc. (NIO) closed the most recent trading day at $10.92, moving -0.09% from the previous trading session.

  • Here's What Key Metrics Tell Us About Lumen (LUMN) Q4 Earnings

    The headline numbers for Lumen (LUMN) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

  • BP hikes dividend, Apollo in talks for Credit Suisse unit, SoftBank battles slumping valuations

    Yahoo Finance's Julie Hyman breaks down notable business headlines, which include BP posting record profits and slowing its shift away from oil, Apollo Global Management exploring a stake in a Credit Suisse unit, and SoftBank's vision fund battling hit by a tech slump. (Apollo Global Management is Yahoo Finance's parent company.)

  • Why Lithium Americas Stock Jumped 8% Today

    Shares of start-up lithium miner -- and General Motors partner -- Lithium Americas (NYSE: LAC) soared 8.1% through 11:50 a.m. ET on Tuesday, after a federal district court in Nevada issued what the company called a "favorable ruling" in an appeal against a Bureau of Land Management (BLM) ruling. As Reuters relates, the U.S. District Court for the District of Nevada instructed the BLM to consider whether Lithium Americas should be permitted to dump waste rock from its Thacker Pass lithium project at a location just south of the Oregon border. In short, Lithium Americas now has a green light to proceed with exploitation of what Lithium Americas calls "the largest known lithium resource in the U.S." It keeps the company on track to begin producing up to 40,000 tons of lithium carbonate per year by late 2026, and as much as 80,000 tons per year in a later Phase 2 of the project.

  • CVS Health (CVS) Q4 Earnings and Revenues Top Estimates

    CVS Health (CVS) delivered earnings and revenue surprises of 3.65% and 11.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Uber reports key revenue and bookings beat

    Uber reported its Q4 2022 earnings before the market open.

  • Ford Stock: The Good, the Bad, and the Ugly

    After a turbulent 2022 for the automotive industry, investors were thrilled when General Motors posted surprisingly strong fourth-quarter results. The better-than-expected earnings on strong revenue drove GM stock higher, and it also pulled competitor Ford Motor Company (NYSE: F) stock higher in anticipation it would have similar results. Worse yet, Ford management didn't have many details about its plan to fix its problems -- at least, not yet.

  • Emerson unveils its headquarters location

    The Ferguson-based automation and software giant's decision about a headquarters location follows the sale of its local base last year and caps a search the company had said would include locations outside St. Louis.

  • The Worst Mistake AMD Investors Can Make in 2023

    The chipmaker's guidance for the current quarter isn't great, but there's more to it than meets the eye.

  • Morgan Stanley: Prices for Rolex, Patek Philippe and Audemars Piguet watches will keep plunging due to a flood of supply — here are 3 real assets that remain scarce and coveted

    Time flies. But it also crashes.

  • BlackRock Bets Big on These 2 High-Quality and Profitable Stocks

    We’ve seen the markets take a breather recently and that is hardly surprising considering the year-to-date rally. Stocks charged out the gate in 2023 as if in a hurry to consign 2022’s annus horribilis to the history bins. Observing the sharp and abrupt shift in sentiment, BlackRock's bond chief Rick Rieder has called the surge "extraordinary." However, Rieder, who handles around $2.4 trillion in assets, is not quite ready to get the bull outfit on just yet. Given the widespread compression in p

  • Devon Energy (DVN) Earnings Expected to Grow: Should You Buy?

    Devon Energy (DVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • 3 Nasdaq 100 Stocks to Buy Hand Over Fist in February

    After growth stocks were Wall Street's savior in 2021, they were primarily responsible for dragging the major indexes into a bear market last year. The growth-dependent Nasdaq Composite and Nasdaq 100 -- an index comprised of the 100 largest nonfinancial companies listed on the Nasdaq exchange -- each plunged 33% in 2022. Thankfully, when there's pain on Wall Street, you can always find opportunity.

  • Disney earnings: What to expect from Bob Iger’s plan

    Yahoo Finance Live anchors discuss the expectations for Disney earnings following the return of CEO Bob Iger.

  • Which States Don’t Tax Social Security Benefits?

    Of the 50 U.S. states, 39 and the District of Columbia do not levy a tax on Social Security benefits.